Purchases and Sales Made in Q4 2021 in Processa Pharmaceuticals, Inc. (PCSA)
This table provides information about the institutional ownership of Processa Pharmaceuticals, Inc. (PCSA) during Q4 2021. The information is specifically focused on institutions that hold shares of Processa Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2022
Q4 2021
|
Coastal Bridge Advisors, LLC
|
BUY
|
- |
5K+ 18.18% |
$20.2K - $42.1K
|
32.5K
$31.9K
|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
3.48K+ 12.87% |
$14K - $29.3K
|
30.5K
$29.9K
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.61KNew |
$6.5K - $13.6K
|
1.61K
$1.58K
|
|
Feb 14, 2022
Q4 2021
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
1KNew |
$4.03K - $8.42K
|
1K
$980
|
|
Feb 08, 2022
Q4 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
7New |
$28.2 - $58.9
|
7
$6.86
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-68Closed |
$274 - $573
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-293- 0.08% |
$1.18K - $2.47K
|
374K
$366K
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
SELL
|
- |
-328- 60.07% |
$1.32K - $2.76K
|
218
$214
|
|
Feb 02, 2022
Q4 2021
|
Heritage Wealth Advisors
|
SELL
|
- |
-1KClosed |
$4.03K - $8.42K
|
0
$0
|
|
Feb 10, 2022
Q4 2021
|
Essex Investment Management CO LLC
Boston, MA |
SELL
|
- |
-1.17K- 1.57% |
$4.7K - $9.82K
|
73.2K
$71.7K
|
|
Jan 26, 2022
Q4 2021
|
Verdence Capital Advisors LLC
Hunt Valley, MD |
SELL
|
- |
-10.6K- 14.31% |
$42.6K - $88.9K
|
63.2K
$62K
|
|
Feb 14, 2022
Q4 2021
|
Worth Venture Partners, LLC
Fort Lee, NJ |
SELL
|
- |
-20K- 22.0% |
$80.7K - $169K
|
71K
$69.5K
|
|
Feb 10, 2022
Q4 2021
|
Aigh Capital Management LLC
Baltimore, MD |
SELL
|
- |
-83.4K- 21.54% |
$336K - $702K
|
304K
$298K
|